AMN107: Leukemia Wonder Drug

A compound called AMN107 has been found to cause remission in 86 percent of patients with chronic myeloid leukemia who do not respond to the other wonder drug Gleevec (in use since 2001). The human trial is only in Phase I (compound safety in humans) but the results have been so incredible that scientists have had difficulty keeping quiet about it.

AMN107 is only one example of many new and powerful treatments for various diseases. As a result of treating or curing diseases, we are faced with life extension. Some critics argue that curing diseases does not extend life, but how long would patients in this trial have lived without AMN107? Their lifespan has in fact been extended!

Published by

Richard Leis

Richard Leis is a fiction writer and poet, with his first published poem forthcoming later in 2017 from Impossible Archetype. His essays about fairy tales and technology have been published on Tiny Donkey. Richard is also the Downlink Lead for the High Resolution Imaging Science Experiment (HiRISE) team at the University of Arizona. He monitors images of the Martian surface taken by the HiRISE camera located on board the Mars Reconnaissance Orbiter in orbit around Mars and helps ensure they process successfully and are validated for quick release to the science community and public. Once upon a time, Richard wrote and edited the science and technology news and commentary website Frontier Channel, hosted the RADIO Frontier Channel podcast, and organized transhumanist clubs. Follow Richard on his website (richardleis.com), on Goodreads (richardleis), his Micro.blog (@richardleis), Twitter (@richardleisjr), and Facebook (richardleisjr).